Use of Low Doses of Interleukin-2 in Autism Spectrum Disorders

NCT07589842 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
22
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators